Why MEDS rose 23.4% on Sep 17 2026: helomics acquisition
MEDS+23.4%on Thu Sep 17 2026
DataMeds AI, Inc. Common Stock was up 23.4% on the day at $7.49, ranked #8 on — its usual five-minute volume, when TapeRank recorded this spike at 04:02 ET during the pre-market session.
WHAT THE ROW LOOKED LIKE
LAST7.49
DAY▲ 23.4%
5 MIN▲ 9.50%
5M RVOL—
5M $VOL$538K
FLOAT*3.2M
RANK#8
SESSIONPRE-MARKET
* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
AI VERDICT
STRETCHEDCONFIDENCE5/5
MEDS is up 18.1% pre-market after a prior circuit-breaker halt and coverage of its Helomics acquisition. The deal provides an acquired subsidiary but was funded with 636,328 shares and a convertible note, so the sharp move is far larger than the disclosed, non-quantified operating news supports and carries clear issuance risk.
WHYAn 18.1% move, following a reported 311.73% surge, is outsized relative to an acquisition funded by 19.99% in stock and a convertible note rather than a quantified earnings or approval catalyst.
ANALYZED 04:01 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNA
FILINGS · 24H BEFORE THE MOVE
- WED 21:35 ETNebius Group, DataMEDS AI, Boeing, Generac Holdings and Delixy Holdings: Why These 5 Stocks Are on Investors' Radars TodayBenzinga
- WED 13:11 ET8-K — Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and ExhibitsSEC 8-K
- WED 10:44 ETDataMeds AI Shares Halted On Circuit Breaker To The Upside, Stock Now Up 311.73%Benzinga
SESSION LEVELS AT CAPTURE
VWAP7.44
HOD8.04
LOD6.84
OR HIGH—
OR LOW—
PREV CLOSE6.07
PM HIGH8.04
PM LOW6.84
GAP▲ 32.43% (indicated)
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO